Literature DB >> 20436310

Deep vein thrombosis and pulmonary embolism in pregnancy: diagnosis, complications, and management.

Haywood L Brown1, Adam K Hiett.   

Abstract

Venous thromboembolism is a leading cause for maternal mortality. Because of the increase risk for thromboembolism in pregnancy and the postpartum period, the clinician must be on high alert for the signs and symptoms and use appropriate diagnostics in a timely manner so that prompt anticoagulation therapy can be initiated. A diagnostic and management approach for both deep vein thrombosis and pulmonary embolism and for prophylaxis against thromboembolism in the obstetric patient are crucial to decreasing morbidity, mortality, and long-term sequelae.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20436310     DOI: 10.1097/GRF.0b013e3181deb27e

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  6 in total

1.  Risk factors for venous thrombosis associated with peripherally inserted central venous catheters.

Authors:  Longfang Pan; Qianru Zhao; Xiangmei Yang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States.

Authors:  Karon Abe; Elena V Kuklina; W Craig Hooper; William M Callaghan
Journal:  Semin Perinatol       Date:  2019-03-09       Impact factor: 3.300

Review 3.  Imaging for the exclusion of pulmonary embolism in pregnancy.

Authors:  Thijs E van Mens; Luuk Jj Scheres; Paulien G de Jong; Mariska Mg Leeflang; Mathilde Nijkeuter; Saskia Middeldorp
Journal:  Cochrane Database Syst Rev       Date:  2017-01-26

4.  Enoxaparin Dosing and AntiXa Monitoring in Specialty Populations: A Case Series of Renal-Impaired, Extremes of Body Weight, Pregnant, and Pediatric Patients.

Authors:  Tania Ahuja; Katie Mariam Mousavi; Liana Klejmont; Sonya Desai
Journal:  P T       Date:  2018-10

5.  How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?

Authors:  Lucia Stanciakova; Miroslava Dobrotova; Pavol Holly; Jana Zolkova; Lubica Vadelova; Ingrid Skornova; Jela Ivankova; Matej Samos; Tomas Bolek; Marian Grendar; Jan Danko; Peter Kubisz; Jan Stasko
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

Review 6.  A Useful Blood Flow Restriction Training Risk Stratification for Exercise and Rehabilitation.

Authors:  Dahan da Cunha Nascimento; Nicholas Rolnick; Ivo Vieira de Sousa Neto; Richard Severin; Fabiani Lage Rodrigues Beal
Journal:  Front Physiol       Date:  2022-03-11       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.